Journal
EUROPEAN JOURNAL OF PHARMACOLOGY
Volume 469, Issue 1-3, Pages 81-88Publisher
ELSEVIER SCIENCE BV
DOI: 10.1016/S0014-2999(03)01735-7
Keywords
agmatine; antidepressant; PC12 cell; monoamine; Ca2+
Categories
Ask authors/readers for more resources
In mammalian brain, agmatine is an endogenous neurotransmitter and/or neuromodulator, which is considered as an endogenous ligand for imidazoline receptors. In this study, the antidepressant-like action of agmatine administered p.o. or s.c. was evaluated in three behavioral models in mice or rats. Agmatine at doses 40 and 80 mg/kg (p.o.) reduced immobility time in the tail suspension test and forced swim test in mice or at dose 20 mg/kg (s.c.) in the forced swim test. Agmatine also reduced immobility time at 10 mg/kg (p.o.) or at 1.25, 2.5 and 5 mg/kg (s.c.) in the forced swim test in rats. These results firstly indicated that agmatine possessed an antidepressant-like action. With 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay and lactic dehydrogenase (LDH) assay, 1, 10 and 100 muM agmatine or a classical antidepressant, 2.5 and 10 muM desipramine, protected PC12 cells from the lesion induced by 300 muM N-methyl-D-aspartate (NMDA) treatment for 24 h. Using high-performance liquid chromatography with electrochemical detection (HPLC-ECD), it was found that the levels of monoamines including norepinephrine, epinephrine, dopamine or 5-hydroxytryptamine (5-HT) in PC 12 cells decreased after the treatment with 200 muM NMDA for 24 h, while in the presence of 1 and 10 muM agmatine or 1 and 5 muM desipramine, the levels of norepinephrine, epinephrine or dopamine were elevated significantly while 5-HT did not change. Moreover, norepinephrine, 5-HT or dopamine had the same cytoprotective effect as agmatine at doses 0.1, 1 and 10 muM. In the fura-2/AM (acetoxymethyl ester) labeling assay, 1 and 10 muM agmatine, 1 and 5 muM desipramine or monoamines norepinephrine, 5-HT at doses 0.1 and 1 muM attenuated the intracellular Ca2+ overloading induced by 200 muM NMDA treatment for 24 h in PC12 cells. In summary, we firstly demonstrated that agmatine has an antidepressant-like effect in mice and rats. A classical antidepressant, desipramine, as well as agmatine or monoamines protect the PC12 cells from the lesion induced by NMDA treatment. Agmatine reverses the NMDA-induced intracellular Ca2+ overloading and the decrease of monoamines (including norepinephrine, epinephrine or dopamine) contents in PC12 cells, indicating that agmatine's antidepressant-like action may be related to its modulation of NMDA receptor activity and/or reversal of the decrease of monoamine contents and Ca2+ overloading induced by NMDA. (C) 2003 Elsevier Science B.V All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available